Most active investors · Jan 1, 2026 – Oct 26, 2026
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 26, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Series A 2
Beyang Therapeutics $30M Series ACORE Biomedicine $21M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Palette €3M Pre-SeedOrigin $30M Series A+Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
DR. VIVIEN KARL Undisclosed SeedGardia €8.5M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Series B 2
Vaderis Therapeutics $152M Series BAltesa BioSciences $75M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Soctera $4M SeedKanvas Biosciences $48M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series B 1
ApartmentIQ $25M Follow-on investmentVisitt $22M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
Neros Technologies $250M Series CAlloy Therapeutics $40M Series EDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
Zerolook CHF 1.5M Pre-seedArtificial Labs $45M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Silicon Data $30.5M Series ATrue Anomaly $650M Series DDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
DR. VIVIEN KARL Undisclosed SeedVisioLab $11M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Natural $30M Series AAmbrook $30M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 2
Aureka Biotechnologies $100M Series BEvoken ~$300M Series B+Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Aureka Biotechnologies $100M Series BVivatides Therapeutics $54M Series ADetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
Cambridge Aerospace $300M Series CStord $250M Series FDetails
New companies 2 · Follow-on 0
Stages: Series B 2
Aureka Biotechnologies $100M Series BEPG $100M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Flagler Health $50M Series BThrone Science $10M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Plinq R$1.3M First funding roundPaper $34M Series ADetails
New companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Factbird Undisclosed Strategic majority investmentSerpier €1.4M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Point2 Technology $136M Series BHyperLight Corporation $80M Series CDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
NavVis $85M Series DTRUCE Software Undisclosed Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series B 1
Vedanta Biosciences $60M GrowthILiAD Biotechnologies $115M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Avatar Robotics $6.5M SeedSynthpop, Inc. $15M Series ADetails
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.